WHETHER CHIDAMIDE IMPROVES THE RESPONSE TO CISPLATIN IN FIRST-LINE TREATMENT OF METASTATIC TRIPLE-NEGATIVE BREAST CANCER

被引：0
|
作者：
Zhang, Jian [1 ]
Hu, Xichun [1 ]
Meng, Yanchun [1 ]
Jin, Juan [1 ]
Gong, Chengcheng [1 ]
Miao, Haitao [1 ]
Tao, Zhonghua [1 ]
Li, Ting [1 ]
Cao, Jun [1 ]
Wang, Leiping [1 ]
Wang, Biyun [1 ]
Hu, Xichun [1 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
BREAST | 2021年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO56
引用
收藏
页码：S46 / S46
页数：1
相关论文
共 50 条
  • [31] First-line chemotherapy with docetaxel and cisplatin in metastatic breast cancer
    Vassilomanolakis, M
    Koumakis, G
    Barbounis, V
    Demiri, M
    Panopoulos, C
    Chrissohoou, M
    Apostolikas, N
    Efremidis, AP
    BREAST, 2005, 14 (02): : 136 - 141
  • [32] Carboplatin-Cyclophosphamide or Paclitaxel without or with Bevacizumab as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (BOOG 2013-01)
    Van Rossum, Annelot G. J.
    Mandjes, Ingrid A. M.
    Van Werkhoven, Erik
    Van Tinteren, Harm
    Van Leeuwen-Stok, A. Elise
    Nederlof, Petra
    Portielje, Johanna E. A.
    Van Alphen, Robbert J.
    Platte, Els
    Van den Broek, Daan
    Huitema, Alwin
    Kok, Marleen
    Linn, Sabine C.
    Oosterkamp, Hendrika M.
    BREAST CARE, 2021, 16 (06) : 598 - 606
  • [33] Efficacy of gemcitabine and cisplatin (GP) as first-line combination therapy in patients with triple-negative metastatic breast cancer: Prclineinary results report of a phase II trial
    Wang, Z.
    Hu, X.
    Chen, L.
    Wang, J.
    Wang, H.
    Wang, L.
    Liu, G.
    Hu, Z.
    Wu, J.
    Zhimin, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] Pretreatment Heterogeneity Predicts Treatment Outcome Of First-line Chemotherapy In Patients With Metastatic Triple Negative Breast Cancer
    Gong, C.
    Ma, G.
    Hu, X.
    Zhang, Y.
    Wang, Z.
    Zhang, J.
    Zhao, Y.
    Li, Y.
    Xie, Y.
    Yang, Z.
    Wang, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S458 - S459
  • [35] Metastatic and triple-negative breast cancer: challenges and treatment options
    Sumayah Al-Mahmood
    Justin Sapiezynski
    Olga B. Garbuzenko
    Tamara Minko
    Drug Delivery and Translational Research, 2018, 8 : 1483 - 1507
  • [36] A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer
    Zeichner, Simon B.
    Terawaki, Hiromi
    Gogineni, Keerthi
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2016, 10
  • [37] Emerging treatment strategies for metastatic triple-negative breast cancer
    Huppert, Laura A.
    Gumusay, Ozge
    Rugo, Hope S.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [38] Metastatic and triple-negative breast cancer: challenges and treatment options
    Al-Mahmood, Sumayah
    Sapiezynski, Justin
    Garbuzenko, Olga B.
    Minko, Tamara
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2018, 8 (05) : 1483 - 1507
  • [39] Treatment patterns in metastatic triple-negative breast cancer (mTNBC).
    Jiang, Shan
    Hill, Kala
    Della Varghese
    Waldeck, Adrian Reg
    Botteman, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [40] Innovations and Challenges in the Treatment of Metastatic Triple-Negative Breast Cancer
    McArthur, Heather L.
    JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (05) : 290 - +
12345